First Generic Versions of Depakote Approved
Posted by admin
Font Size A A A
First Generic Versions of Depakote Approved
TUESDAY, July 29 (HealthDay News) — The first generic versions of depakote (divalproex sodium) have been approved by the U.S. Food and Drug Administration to treat epileptic seizures, migraine headaches and bipolar disorder, the agency said Tuesday.
Latest Medications News
- Genetic Cause of Statin-Related pain help/muscle relaxant Pain Found
- vytorin Fails to Lower Heart Valve Problems
- Kidney Patients Unlikely to Get Heart Attack Meds
- topamax May Raise Risk of Birth Defects
- Gene Variation May Predict Antidepressant Response
- Want More News? Sign Up for MedicineNet Newsletters!
Eight firms were granted license to produce generic versions of the brand-name drug made by Abbott Laboratories. The generics will have the same label warnings as the brand-name medication, including cautions about increased risk of severe liver damage, inflamed pancreas, and neural tube birth defects.
“Generic drugs experience a rigorous scientific review to make secure that they will provide the patient with the same amount of high quality, unscathed and effective drug as the term brand product,” Gary Buehler, director of the FDA’s Office of Generic Drugs, said in some mediation news release.
Copyright © 2008 ScoutNews, LLC. All rights reserved.
- News Articles
- 1
- 2
- 3
- 4
- 5
- Next Article: Genetic Cause of Statin-Related Muscle pain relief/muscle relaxant Found »
Leave a Reply